ONC201 for the Treatment of Newly Diagnosed H3 K27M-mutant Diffuse Glioma Following Completion of Radiotherapy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study (ACTION)

Principal Investigator

Dr Meera Nandhabalan

Contact us

Email: latephaseoncology@ouh.nhs.uk

IRAS number

1006536